Challenges associated with curcumin therapy in Alzheimer disease.

Expert reviews in molecular medicine

Volumn 13, Issue , 2011, Pages

  Belkacemi, Abdenour ^a   Doggui, Sihem ^b   Dao, Lé ^b   Ramassamy, Charles ^b  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CURCUMIN;

ALZHEIMER DISEASE; CLINICAL TRIAL (TOPIC); HUMAN; METABOLISM; OXIDATIVE STRESS; REVIEW;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CLINICAL TRIALS AS TOPIC; CURCUMIN; HUMANS; OXIDATIVE STRESS;

MLCS; MLOWN;

EID: 84857098192     PISSN: None     EISSN: 14623994     Source Type: Journal    
DOI: 10.1017/s1462399411002055     Document Type: Review

References (0)